Showing results (21-30 of 264) with videos related to
Sort By:
Pageof 27
British Journal of Haematology|October 31, 2002
Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndromeFrancesc Cobo, Laura Rosiñol, Antonio Martínez, et al.Oncogene|October 14, 2004
Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genesAna Ferrer, Silvia Marcé, Beatriz Bellosillo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemiaCarol Moreno, Neus Villamor, Dolors Colomer, et al.Blood|January 5, 2002
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalancesEmma Camacho, Luis Hernández, Silvia Hernández, et al.Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Critical molecular pathways in CLL therapyGerardo Ferrer, Emili MontserratCurrent Opinion in Oncology|August 29, 2009
Genetic lesions in chronic lymphocytic leukemia: clinical implicationsEmili Montserrat, Carol MorenoClinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?Emili Montserrat, Peter DregerBlood Reviews|May 2, 2008
New prognostic markers in chronic lymphocytic leukemiaCarol Moreno, Emili MontserratCurrent Hematologic Malignancy Reports|February 6, 2015
Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?Peter Dreger, Emili Montserrat, , et al.Cancer|August 6, 2019
Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertaintyEmili Montserrat, Robert Peter GalePageof 27